In The News

Cross-Practice Team Leads Debt Offering for Ironwood Pharmaceuticals

Practices: Finance, Life Sciences

A Ropes & Gray team represented Ironwood Pharmaceuticals, Inc. in the completion of a debt offering of $175 million, announced on Jan. 4. Ironwood intends to use the net proceeds from this transaction to fund its research and development efforts and to support the commercial launch of LINZESS™ (linaclotide), its intestinal pain reduction medication.

The team included securities & public companies partners Patrick O'Brien and Paul Kinsella, and tax partner David Saltzman. It also included finance associates Amy Olson, Scott Ollivierre and Bryan LaPlant, benefits associate Josh Lichtenstein, tax associate Benjamin Rogers, corporate associate Abigail Hackler, and senior real estate paralegal Christina Fulham.
Cookie Settings